Accordingly, commonly used drugs that are administered in patients to control glucose and cholesterol metabolism are subjects of study for MeCP2-associated disorders such as Rett Syndrome and other diseases of the brain such as brain tumors [18,20,104,232,233,234,235]. Here, MECP2 is linked to atypical Rett syndrome.